Alterations of membrane protein expression in red blood cells of Alzheimer's disease patients

Preventive measures, prognosis, or selected therapy in multifactorial maladies, including Alzheimer's disease (AD), require the application of a wide range of diagnostic assays. There is a large unmet need for relatively simple, blood-based biomarkers in this regard. We have recently developed...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Várady György
Szabó Edit Zsuzsanna
Fehér Ágnes
Németh Adrienn
Zámbó Boglárka
Pákáski Magdolna
Janka Zoltán
Sarkadi Balázs
Dokumentumtípus: Cikk
Megjelent: Elsevier 2015
Sorozat:ALZHEIMERS & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING 1 No. 3
doi:10.1016/j.dadm.2015.06.007

mtmt:2938273
Online Access:http://publicatio.bibl.u-szeged.hu/11140
LEADER 01996nab a2200289 i 4500
001 publ11140
005 20231220082652.0
008 170407s2015 hu o 0|| zxx d
022 |a eISSN: 2352-8729 
024 7 |a 10.1016/j.dadm.2015.06.007  |2 doi 
024 7 |a 2938273  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Várady György 
245 1 0 |a Alterations of membrane protein expression in red blood cells of Alzheimer's disease patients  |h [elektronikus dokumentum] /  |c  Várady György 
260 |a Elsevier  |c 2015 
300 |a 334-338 
490 0 |a ALZHEIMERS & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING  |v 1 No. 3 
520 3 |a Preventive measures, prognosis, or selected therapy in multifactorial maladies, including Alzheimer's disease (AD), require the application of a wide range of diagnostic assays. There is a large unmet need for relatively simple, blood-based biomarkers in this regard. We have recently developed a rapid and reliable flow cytometry and antibody-based method for the quantitative measurement of various red blood cell (RBC) membrane proteins from a drop of blood. Here, we document that the RBC expression of certain membrane proteins, especially that of the GLUT1 transporter and the insulin receptor (INSR), is significantly higher in AD patients than in age-matched healthy subjects. The observed differences may reflect long-term metabolic alterations relevant in the development of AD. These findings may pave the way for a diagnostic application of RBC membrane proteins as relatively stable and easily accessible personalized biomarkers in AD. © 2015 The Authors. 
700 0 1 |a Szabó Edit Zsuzsanna  |e aut 
700 0 1 |a Fehér Ágnes  |e aut 
700 0 1 |a Németh Adrienn  |e aut 
700 0 1 |a Zámbó Boglárka  |e aut 
700 0 1 |a Pákáski Magdolna  |e aut 
700 0 1 |a Janka Zoltán  |e aut 
700 0 1 |a Sarkadi Balázs  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/11140/1/alterations.pdf  |z Dokumentum-elérés